Jessica Meisner, MD, MS, MSHP

Infectious Diseases
Accepting new patients
Sees patients age 18 and up
MacGregor Infection Medicine and Travel Program
Make an appointmentCall 800-789-7366
Headshot of Jessica Meisner, MD, MS, MSHP
Penn Medicine Provider

About me

  • Medical Director of HIV clinic, Prevention Point
  • Associate Professor of Clinical Medicine (Infectious Diseases)

My education and training

  • Medical School: Drexel University College of Medicine
  • Residency: Beth Israel Deaconess Medical Center
  • Fellowship: University of Pennsylvania Health System

Spoken languages

English
English

Insurance accepted

Please contact the practice and/or the member services department of your insurance company for specific details before receiving services. Providers may participate in some, but not all, products offered by a health plan; providers may also accept plans at some practice locations but not others.

Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Dr. Meisner is a Penn Medicine physician.

Qualifications and experience

Treatments and Conditions

Research

Publications

Karissa Chow, Amanda Binkley, Jessica Meisner, Samantha Huo, Matthew Hinton Managing the Complex Intersection Between Substance Use Disorders and Infectious Diseases: A Case Study , Journal of the American College of Clinical Pharmacy: 2026

Amanda Perez1 & Elizabeth Whidden1, Olivia Duffield1, Rachael Truchil1, Jeffrey Jaeger2, Jessica Meisner1, 3, Nichole Smith1, M. Elle Saine1 Retention and Predictors of Engagement in Three Integrated Primary Care MOUD Clinics within an Academic Health System". , ASAM 2026: 2026

Elizabeth Whidden1, Amanda Perez1, Olivia Duffield1, Jeffrey Jaeger2, Jessica Meisner1, 3, Nichole Smith1, Rachael Truchil1, 4 & M. Elle Saine1, 5 Early Uptake and Utilization Patterns of Long-Acting Injectable Buprenorphine , American Society of Addiction Medicine: 2026

Yang WT, Meisner JA, Maguire C, Dyer KE, McFadden R, Thakrar AP, Dickinson DT, Berg D, Preston A, David MZ, Perrone J, Talati N, Degnan KO. Multidisciplinary Guidance to Care for Persons With Xylazine-Associated Wounds. , Open Forum Infect Dis, 12(6): 2025

Kelly PJA, Jessop AB, Scialanca M, Singley K, Luck CC, Hoadley A, Meisner J, Bass SB. Psychosocial Impact of Suspected Xylazine-Associated Skin Wounds Among People Using Fentanyl, Philadelphia, 2022 to 2023 , Subst Use Addctn J: 2024

Amanda Perez, Shane Nieves, Jessica Meisner Outcomes of LA-ART at a syringe exchange , Open Forum Infectious Diseases: 2024

Nicole Loeven, Eric Altneu, Virginie Halpern-Cohen, Kelly Dyer, Kaede Sullivan, Shara Epstein, Daniel Teixera da Silva, Jessica Meisner, Sara Schultz Increase in iGAS seen at two urban quarternary care centers in Philadelphia: Association with PWID and the unstably housed. , IDWeek2023 : 2023

Kruti J. Yagnik, Jessica A. Meisner Laboratory Testing Strategies, Detection and Diagnosis In Fundamentals of HIV Medicine 2023 Edition , AAHIVM, W David Hardy , Chapter 8: 2023,71-77

N. Loeven, K. Dyer, V. Halpern-Cohen, C. Comar, J. Meisner, L. Glaser; Macrolide and Lincosamide Susceptibility Profiles and Use of Clindamycin for iGAS in One Hosp. in Philadelphia, 2018 - 2022 , American Society of Microbiology: 2023

Zwiebel S, Meisner J, Lowenstein M National Trends in Medical and Surgical Decision-Making for Recurrent Injection Drug Use-Related Infective Endocarditis: A Survey , J Acad Consult Liaison Psychiatr, 64(1): 2023,96-98